Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2Paul D. Wright, Alistair Mathie, David McCoull et al.|Biochemical and Biophysical Research Communications|2019Cited by 21
Aprepitant is a novel, selective activator of the K2P channel TRAAKDavid McCoull, Paul D. Wright, Jonathan M. Large et al.|Biochemical and Biophysical Research Communications|2021Cited by 8